Spero Therapeutics (SPRO) Receives FDA Fast Track Designation for SPR994 for treatment of cUTI and Acute Pyelonephritis - StreetInsider.com

Spero Therapeutics (SPRO) Receives FDA Fast Track Designation for SPR994 for treatment of cUTI and Acute Pyelonephritis  StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Spero Therapeutics, Inc. (Nasdaq: SPRO), ...



Comments

Popular posts from this blog

Uveitis Eye Inflammation Causes, Symptoms & Treatment

Robert Zakar gives back to community

Goopy Eyes: Causes and Treatment